Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

59,000

Employees59,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

59,000

Employees59,000

BSX Key Statistics

Market cap

69.70B

Market cap69.70B

Price-Earnings ratio

19.78

Price-Earnings ratio19.78

Dividend yield

—

Dividend yield—

Average volume

21.05M

Average volume21.05M

High today

$47.80

High today$47.80

Low today

$45.99

Low today$45.99

Open price

$47.43

Open price$47.43

Volume

16.76M

Volume16.76M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$45.99

52 Week low$45.99

Stock Snapshot

With a market cap of 69.7B, Boston Scientific(BSX) trades at $46.91. The stock has a price-to-earnings ratio of 19.78.

During the trading session on 2026-06-13, Boston Scientific(BSX) shares reached a daily high of $47.80 and a low of $45.99. At a current price of $46.91, the stock is +2.0% higher than the low and still -1.9% under the high.

Trading activity shows a volume of 16.76M, compared to an average daily volume of 21.05M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $45.99.

BSX News

Simply Wall St 9h

Boston Scientific’s Penumbra Deal Gains Weight With Thunderbolt Stroke Clearance

Penumbra, which Boston Scientific (NYSE:BSX) agreed to acquire in early 2026, has received FDA clearance for its Thunderbolt computer assisted vacuum thrombecto...

TipRanks 17h

Boston Scientific price target lowered to $65 from $90 at Piper Sandler

Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Boston Scientific (BSX) to $65 from $90 and keeps an Overweight rating on the shares. The...

Simply Wall St 2d

Softer WATCHMAN Outlook And Buybacks Could Be A Game Changer For Boston Scientific

Recently, Boston Scientific reduced its earnings guidance and updated expectations for its WATCHMAN and ablation franchises, while also entering a US$2.00 billi...

Analyst ratings

86%

of 35 ratings

Buy

85.7%

Hold

14.3%

Sell

More BSX News

TipRanks 3d

Boston Scientific Targets Diabetes and Obesity With New ESG Trial

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific is launching a new trial called “Metabolic Effects of Endoscopic...

TipRanks 3d

Boston Scientific’s RESCUE Study Termination: What It Means for ESG and Obesity Investments

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific’s RESCUE study, formally titled “Evaluation of Endoscopic Sleeve...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.